Triage value of methylation detection in cervical cancer and precancerous lesions

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100048354

Enrollment

Unknown

Registered

2021-07-06

Start date

2021-09-01

Completion date

Unknown

Last updated

2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer and pre-cancer lesion

Interventions

Gold Standard:Pathology of colposcopy.

Index test:S5 methylation.

Eligibility

Sex/Gender

Female

Age

27 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.HPV16/18 positive and/or abnormal cytology (TCT>=HSIL+); 2.Female aged 27 to 70 years with sexual life history; 3.Consent to the collection of cervical epithelial exfoliated cells for this study, and sign the informed consent; 4.The patient underwent colposcopy examination and had clear pathological results.

Exclusion criteria

Exclusion criteria: 1.Pregnancy status; 2.History of uterine and cervical surgery; 3.Complications of other immune system diseases.

Design outcomes

Primary

Measure	Time frame
pathology results;	—

Countries

China

Contacts

Public ContactHua Keqin

Obstetrics and Gynecology Hospital of Fudan University

huakeqin@126.com+86 15921515900

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026